Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Dalteparin × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 15 Gastrointestinal 7 Thoracic 4 Sarcoma 3 Plasma cell 3 Lymphoid 2 Gynecologic 2 Genitourinary 2 CNS 2 Tumor-Agnostic 1 Other neoplasm 1 Other hematologic neoplasm 1 Other 1 Myeloid 1 Dermatologic 1 Breast 1

Conditions

Venous Thromboembolism 1 Obesity 1 Neoplasms 1

Interventions

Exercise 24 Metformin 19 Methods 12 Early Intervention, Educational 12 Radiotherapy 11 Standard of Care 10 Educational Status 10 Counseling 10 Diet Therapy 8 naloxegol 7 Surveys and Questionnaires 7 Nutrition Assessment 7 Diet 7 alvimopan 6 Tirzepatide 6 Resistance Training 6 Psychiatric Rehabilitation 6 Cisplatin 6 Caloric Restriction 6 Radiation 5 Exenatide 5 Dexamethasone 5 Therapeutics 4 Specimen Handling 4 Mouthwashes 4 Morphine 4 Liraglutide 4 Lidocaine 4 Interviews as Topic 4 Injections 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03297359 2024-01-23

WAVe

Ottawa Hospital Research Institute

Phase 2 Terminated

Classical hematologyOther

Neoplasms, Obesity, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡